Do Racial Differences in Prostate Size Explain Higher Serum Prostate-Specific Antigen Concentrations Among Black Men?

Urology

Volumn 69, Issue 6, 2007, Pages 1138-1142

  Mavropoulos, John C ^a   Partin, Alan W ^d   Amling, Christopher L ^e,h   Terris, Martha K ^f,g   Kane, Christopher J ^i,j   Aronson, William J ^k,l   Presti Jr , Joseph C ^m,n   Mangold, Leslie A ^d   Freedland, Stephen J ^a,b,c  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Alabama   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g MEDICAL COLLEGE OF GEORGIA   (United States)

^h NAVAL MEDICAL CENTER SAN DIEGO   (United States)

ⁱ SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ VA PALO ALTO HEALTH CARE SYSTEM   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CAUCASIAN; COHORT ANALYSIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; NEGRO; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE; PROSTATECTOMY; RACE DIFFERENCE;

AFRICAN AMERICANS; AGED; COHORT STUDIES; HUMANS; MALE; MIDDLE AGED; ORGAN SIZE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN;

EID: 34250010609     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.01.102     Document Type: Article

References (20)

1. Morgan T.O., Jacobsen S.J., McCarthy W.F., et al. Age-specific reference ranges for prostate-specific antigen in black men. N Engl J Med 335 (1996) 304-310
2. Henderson R.J., Eastham J.A., Culkin D.J., et al. Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer. J Natl Cancer Inst 89 (1997) 134-138
3. Freedland S.J., Amling C.L., Dorey F., et al. Race as an outcome predictor after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Urology 60 (2002) 670-674
4. Eastham J.A., and Kattan M.W. Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1-T2 prostate cancer. J Urol 163 (2000) 143-145
5. Pettaway C.A., Troncoso P., Ramirez E.I., et al. Prostate specific antigen and pathological features of prostate cancer in black and white patients: a comparative study based on radical prostatectomy specimens. J Urol 160 (1998) 437-442
6. Roehrborn C.G., Boyle P., Gould A.L., et al. Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia. Urology 53 (1999) 581-589
7. Loeb S., Han M., Roehl K.A., et al. Accuracy of prostate weight estimation by digital rectal examination versus transrectal ultrasonography. J Urol 173 (2005) 63-65
8. Kabalin J.N., McNeal J.E., Johnstone I.M., et al. Serum prostate-specific antigen and the biologic progression of prostate cancer. Urology 46 (1995) 65-70
9. Epstein J.I., Pizov G., and Walsh P.C. Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer 71 (1993) 3582-3593
10. Zhang W., Sesterhenn I.A., Connelly R.R., et al. Inflammatory infiltrate (prostatitis) in whole mounted radical prostatectomy specimens from black and white patients is not an etiology for racial difference in prostate specific antigen. J Urol 163 (2000) 131-136
11. Moul J.W., Connelly R.R., Mooneyhan R.M., et al. Racial differences in tumor volume and prostate specific antigen among radical prostatectomy patients. J Urol 162 (1999) 394-397
12. Ross R., Bernstein L., Judd H., et al. Serum testosterone levels in healthy young black and white men. J Natl Cancer Inst 76 (1986) 45-48
13. Irvine R.A., Yu M.C., Ross R.K., et al. The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res 55 (1995) 1937-1940
14. Wandel C., Witte J.S., Hall J.M., et al. CYP3A activity in African American and European American men: population differences and functional effect of the CYP3A4*1B5'-promoter region polymorphism. Clin Pharmacol Ther 68 (2000) 82-91
15. Gaston K.E., Kim D., Singh S., et al. Racial differences in androgen receptor protein expression in men with clinically localized prostate cancer. J Urol 170 (2003) 990-993
16. Partin A.W., Oesterling J.E., Epstein J.I., et al. Influence of age and endocrine factors on the volume of benign prostatic hyperplasia. J Urol 145 (1991) 405-409
17. Roberts R.O., Jacobson D.J., Girman C.J., et al. Insulin-like growth factor I, insulin-like growth factor binding protein 3, and urologic measures of benign prostatic hyperplasia. Am J Epidemiol 157 (2003) 784-791
18. Hammarsten J., and Hogstedt B. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur Urol 39 (2001) 151-158
19. Xue W., Irvine R.A., Yu M.C., et al. Susceptibility to prostate cancer: interaction between genotypes at the androgen receptor and prostate-specific antigen loci. Cancer Res 60 (2000) 839-841
20. Salomon L., Levrel O., Anastasiadis A.G., et al. Prognostic significance of tumor volume after radical prostatectomy: a multivariate analysis of pathological prognostic factors. Eur Urol 43 (2003) 39-44